April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Immunohistochemical detection of decorin in rat corneal transplants following treatment with immunomodulatory donor bone marrow derived dendritic cells
Author Affiliations & Notes
  • Thomas Ritter
    Medicine, Regenerative Medicine Institute, National University of Ireland, Galway, Galway, Ireland
  • Harry Croke
    Skin and ECM Research Group, Discipline of Anatomy, National University of Ireland, Galway, Galway, Ireland
  • Kristin Kloke
    Skin and ECM Research Group, Discipline of Anatomy, National University of Ireland, Galway, Galway, Ireland
  • Mourice Morcos
    Medicine, Regenerative Medicine Institute, National University of Ireland, Galway, Galway, Ireland
  • Lisa O'Flynn
    Medicine, Regenerative Medicine Institute, National University of Ireland, Galway, Galway, Ireland
  • Fabio Quondamatteo
    Skin and ECM Research Group, Discipline of Anatomy, National University of Ireland, Galway, Galway, Ireland
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 3212. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Thomas Ritter, Harry Croke, Kristin Kloke, Mourice Morcos, Lisa O'Flynn, Fabio Quondamatteo; Immunohistochemical detection of decorin in rat corneal transplants following treatment with immunomodulatory donor bone marrow derived dendritic cells. Invest. Ophthalmol. Vis. Sci. 2014;55(13):3212.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To investigate the immunohistochemical distribution of decorin in the corneal stroma as a potential marker for successful transplantation in a rat corneal transplant model.

Methods: A fully allogeneic rat corneal transplantation model (DA to LEW) was used for in vivo studies. BMDCs were propagated from Dark Agouti (DA) rat bone marrow precursor cells in complete medium supplemented with rat GMCSF (5ng/ml) and IL-4 (5ng/ml). For glucocorticoid treatment of BMDCs, dexamethasone (Dexa) (10uM) was added to the culture. Day 10 donor BMDCs +/- Dexa were harvested and 1x106cells/ml injected intravenously into recipients 7 days prior to corneal transplant surgery. Graft survival and development of opacity, edema and neovascularisation were monitored throughout the therapy. On the average day of rejection (day 17) and on day 30 eyes from different treatment groups were collected, fixed and processed for embedding in paraffin. Five micron sections were cut and stained immunohistochemically by the anti-decorin antibody LF-113 and counter-stained by haematoxylin.

Results: At day 30, in the allografts which did not receive BMDC-treatment, i.e. in the rejected samples, decorin staining showed clear tendency to increase and accumulate in the corneal stroma. In contrast, in allografts at day 30 which received BMDC treatment, staining was much less evident. In the samples taken at the average rejection day, BMDC treated grafts showed higher decorin staining in the corneal stroma. However, in BMDC treated graft samples taken at the average rejection day in which the dendritic cells were treated with Dexamethasone, accumulation of decorin was less evident.

Conclusions: Although preliminary, these results suggest that extracellular matrix rearrangement occurs during corneal transplantation and that better graft integration (30d BMDC treated) displays little decorin accumulation. Therefore, increased decorin deposition could be considered as a novel biomarker in corneal rejection.

Keywords: 480 cornea: basic science • 554 immunohistochemistry • 741 transplantation  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×